Comparativein silicoanalyses and experimental validation of novel splice site and missense mutations in the genesMLH1andMSH2
✍ Scribed by Beate Betz; Stephan Theiss; Murat Aktas; Carolin Konermann; Timm O. Goecke; Gabriela Möslein; Heiner Schaal; Brigitte Royer-Pokora
- Book ID
- 106124112
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 618 KB
- Volume
- 136
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Thirteen families have been described with an autosomal dominantly inherited dementia named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), historically termed Pick's disease. Most FTDP-17 cases show neuronal and/or glial inclusions that stain positively with antibodies r
Stickler syndrome type I (STL1) is a phenotypically heterogeneous disorder characterized by ocular and extraocular features. It is caused by null-allele mutations in the COL2A1 gene that codes for procollagen II. COL2A1 precursor mRNA undergoes alternative splicing, resulting in two isoforms, a long
## Abstract About 4% of all __BRCA1__ and __BRCA2__ alterations reported to the Breast Information Core database are splice site variants. Only a limited number of them have been studied at the RNA level. By __BRCA1__ and __BRCA2__ mutation analysis of breast/ovarian cancer families, we identified
Ornithine transcarbamylase (OTC) deficiency, a X-linked disorder, is the most frequent inborn error of the urea cycle. Point mutations and small deletions/insertions in the OTC gene are responsible for the majority of the cases and have a "private"character with little recurrence. We report on eleve